同时使用毒品、危险饮酒和心理健康障碍对艾滋病毒和丙型肝炎病毒感染者毒品使用模式的影响。
Impact of Co-occurring Drug Use, Hazardous Alcohol Use, and Mental Health Disorders on Drug Use Patterns in People With HIV and Hepatitis C Virus Infection.
作者信息
McCormick Sean, Ward Kathleen M, Sutcliffe Catherine G, Irvin Risha, Chander Geetanjali, Brooner Robert K, Mehta Shruti H, Thomas David L, Sulkowski Mark, Falade-Nwulia Oluwaseun
机构信息
Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland, USA.
出版信息
Open Forum Infect Dis. 2021 Oct 19;8(11):ofab520. doi: 10.1093/ofid/ofab520. eCollection 2021 Nov.
Abstract
Drug use, hazardous alcohol use, and mental health disorders are prevalent among people with HIV and hepatitis C virus (HCV) infection. Co-occurrence of alcohol use and depression negatively impacts substance use patterns. Nevertheless, HCV treatment provides a promising opportunity to identify and address co-occurring drug use, hazardous alcohol use, and mental health disorders.
摘要
药物使用、有害饮酒和精神健康障碍在感染艾滋病毒和丙型肝炎病毒（HCV）的人群中普遍存在。饮酒与抑郁症同时出现会对物质使用模式产生负面影响。然而，丙型肝炎病毒治疗为识别和解决同时存在的药物使用、有害饮酒和精神健康障碍提供了一个有前景的机会。
相似文献
1
Impact of Co-occurring Drug Use, Hazardous Alcohol Use, and Mental Health Disorders on Drug Use Patterns in People With HIV and Hepatitis C Virus Infection.
Open Forum Infect Dis. 2021 Oct 19;8(11):ofab520. doi: 10.1093/ofid/ofab520. eCollection 2021 Nov.
2
Continued Substance Use Among People Living With HIV-Hepatitis-C Co-Infection and Receiving Antiretroviral Therapy.
Subst Use Misuse. 2015;50(12):1536-43. doi: 10.3109/10826084.2015.1023451. Epub 2015 Nov 19.
3
Hepatitis C virus and HIV co-infection in people with severe mental illness and substance use disorders.
AIDS. 2005 Oct;19 Suppl 3:S26-33. doi: 10.1097/01.aids.0000192067.94033.aa.
4
Burden of hepatitis C virus disease and access to hepatitis C virus services in people who inject drugs in India: a cross-sectional study.
Lancet Infect Dis. 2015 Jan;15(1):36-45. doi: 10.1016/S1473-3099(14)71045-X. Epub 2014 Dec 3.
5
Alcohol use disorder and its impact on chronic hepatitis C virus and human immunodeficiency virus infections.
World J Hepatol. 2016 Nov 8;8(31):1295-1308. doi: 10.4254/wjh.v8.i31.1295.
6
Depressive symptoms after hepatitis C cure and socio-behavioral correlates in aging people living with HIV (ANRS CO13 HEPAVIH).
JHEP Rep. 2022 Oct 28;5(1):100614. doi: 10.1016/j.jhepr.2022.100614. eCollection 2023 Jan.
7
Significant reductions in alcohol use after hepatitis C treatment: results from the ANRS CO13-HEPAVIH cohort.
Addiction. 2017 Sep;112(9):1669-1679. doi: 10.1111/add.13851. Epub 2017 Jun 6.
8
The Impact of Markers of HIV Infection on Change in Liver Stiffness in People With HIV and Hepatitis C Virus Co-infection After Treatment and Cure of Hepatitis C.
J Acquir Immune Defic Syndr. 2020 Dec 15;85(5):e81-e89. doi: 10.1097/QAI.0000000000002487.
9
Accelerated and Premature Aging Characterizing Regional Cortical Volume Loss in Human Immunodeficiency Virus Infection: Contributions From Alcohol, Substance Use, and Hepatitis C Coinfection.
Biol Psychiatry Cogn Neurosci Neuroimaging. 2018 Oct;3(10):844-859. doi: 10.1016/j.bpsc.2018.06.006. Epub 2018 Jul 4.
10
Unreported alcohol use was common but did not impact hepatitis C cure in HIV-infected persons who use drugs.
J Viral Hepat. 2020 May;27(5):476-483. doi: 10.1111/jvh.13251. Epub 2020 Jan 7.
引用本文的文献
1
Systematic Review of Cocaine-Treatment Interventions for Black Americans.
Clin Psychol Sci. 2025 Jan;13(1):83-103. doi: 10.1177/21677026241242709. Epub 2024 Apr 23.
本文引用的文献
1
Impact of Hepatitis C treatment on behavioural change in relation to drug use in people who inject drugs: A systematic review.
Int J Drug Policy. 2019 Oct;72:169-176. doi: 10.1016/j.drugpo.2019.05.011. Epub 2019 May 18.
2
A Randomized Controlled Trial of Cash Incentives or Peer Support to Increase HCV Treatment for Persons With HIV Who Use Drugs: The CHAMPS Study.
Open Forum Infect Dis. 2019 Apr 9;6(4):ofz166. doi: 10.1093/ofid/ofz166. eCollection 2019 Apr.
3
Direct-acting antiviral sustained virologic response: Impact on mortality in patients without advanced liver disease.
Hepatology. 2018 Sep;68(3):827-838. doi: 10.1002/hep.29811. Epub 2018 May 14.
4
Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: a multistage systematic review.
Lancet Glob Health. 2017 Dec;5(12):e1192-e1207. doi: 10.1016/S2214-109X(17)30375-3. Epub 2017 Oct 23.
5
High HCV cure rates for people who use drugs treated with direct acting antiviral therapy at an urban primary care clinic.
Int J Drug Policy. 2017 Sep;47:196-201. doi: 10.1016/j.drugpo.2017.07.021. Epub 2017 Aug 12.
6
High hepatitis C cure rates among black and nonblack human immunodeficiency virus-infected adults in an urban center.
Hepatology. 2017 Nov;66(5):1402-1412. doi: 10.1002/hep.29308. Epub 2017 Oct 11.
7
Incidence, risk factors, and prevention of hepatitis C reinfection: a population-based cohort study.
Lancet Gastroenterol Hepatol. 2017 Mar;2(3):200-210. doi: 10.1016/S2468-1253(16)30182-0. Epub 2016 Dec 23.
8
Alcohol use disorder and its impact on chronic hepatitis C virus and human immunodeficiency virus infections.
World J Hepatol. 2016 Nov 8;8(31):1295-1308. doi: 10.4254/wjh.v8.i31.1295.
9
Objective Testing: Urine and Other Drug Tests.
Child Adolesc Psychiatr Clin N Am. 2016 Jul;25(3):549-65. doi: 10.1016/j.chc.2016.02.005. Epub 2016 Mar 30.
10
Prevalence and burden of HCV co-infection in people living with HIV: a global systematic review and meta-analysis.
Lancet Infect Dis. 2016 Jul;16(7):797-808. doi: 10.1016/S1473-3099(15)00485-5. Epub 2016 Feb 25.
Zotero 插件